Deferasirox - NDC Database (Page 5)
69539-021 Nov 20, 2019
Deferasirox 125 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
Deferasirox 125 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
69539-022 Nov 20, 2019
Deferasirox 250 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
Deferasirox 250 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
69539-023 Nov 20, 2019
Deferasirox 500 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
Deferasirox 500 mg Oral Tablet, for Suspension by Msn Laboratories Private Limited
70710-1011 May 06, 2021
Deferasirox 125 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
Deferasirox 125 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
70710-1012 May 06, 2021
Deferasirox 250 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
Deferasirox 250 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
70710-1013 May 06, 2021
Deferasirox 500 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
Deferasirox 500 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals (Usa) Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.